| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680558 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 9 Pages |
Abstract
Multiple-dose ponezumab was generally safe, but not efficacious, in mild-to-moderate AD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jaren W. Landen, Sharon Cohen, Clare B. Jr., Carol Cronenberger, Scot Styren, Aaron H. Burstein, Catherine Sattler, Jae-Hong Lee, Clifford R. Jr., Kejal Kantarci, Pamela F. Schwartz, William T. Duggan, Qinying Zhao, Ken Sprenger, Martin M. Bednar,